This page shows the latest PCSK9 inhibitor news and features for those working in and with pharma, biotech and healthcare.
Praluent was approved in the US first, but Amgen has so far won the key rounds in the legal dispute over PCSK9 inhibitor intellectual property rights. ... This decision is important for patients in the US who will continue to have access to Praluent
PCSK9 inhibitor Repatha (evolocumab) was approved on the strength of data showing it could reduce low-density lipoprotein cholesterol (LDL-c), but health insurers and pharmacy benefit managers in the US ... for their rival PCSK9 inhibitor Praluent
Amgen has won another round in its lawsuit with Sanofi and Regeneron over patent rights to the new PCSK9 inhibitor class of cholesterol-lowering drugs. ... The decision follows an earlier victory for Amgen as it defended patents on its rival PCSK9
Amgen's Repatha unclogs blocked arteries, says study. Looks to boost sales after trial shows clear clinical advantage of PCSK9 inhibitor over statins. ... Despite blockbuster sales projections, PCSK9 inhibitor Repatha (evolocumab) and rival drug Praluent
Pfizer dropping bococizumab casts shadow over PCSK9 class. US payer resistance and diminishing efficacy prompt decision on would-be blockbuster. ... The company's chief executive Ian Read said that experience with already-marketed drugs in the PCSK9
drugs - ALK inhibitor Zykadia (ceritinib) for lung cancer and melanoma treatment Mekinist (trametinib), a MEK inhibitor. ... It also gave the nod to two cholesterol-lowering PCSK9 inhibitors - Sanofi's Praluent (alirocumab) and Amgen's Repatha (evolocumab
More from news
Approximately 10 fully matching, plus 32 partially matching documents found.
AZ has been busy this month and in the deal with J&J, AZ will match its closely-watched PD-L1 checkpoint inhibitor MEDI4736 with Imbruvica. ... In July, BioMarin sold its PRV to Regeneron for $68m to expedite filing of its cholesterol drug, the PCSK9
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Rainmaker is an independent, award-winning communications agency with offices in London and Atlanta. Our experience across pharmaceuticals, generics, OTC, medical...